Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/28004
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHilley, Patrick-
dc.contributor.authorGilmore, Robert B-
dc.contributor.authorSrinivasan, Ashish-
dc.contributor.authorChoy, Matthew C-
dc.contributor.authorDe Cruz, Peter P-
dc.date.accessioned2021-11-16T02:51:10Z-
dc.date.available2021-11-16T02:51:10Z-
dc.date.issued2021-08-19-
dc.identifier.citationInflammatory Bowel Diseases 2021; 27(9): e105-e106en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/28004-
dc.language.isoeng
dc.subjectCrohn diseaseen
dc.subjectcombined biologicsen
dc.subjectinflammatory bowel diseaseen
dc.subjectinfliximaben
dc.subjecttofacitiniben
dc.subjectulcerative colitisen
dc.subjectustekinumaben
dc.titleCombined Targeted Treatment Using Biologic-Tofacitinib Co-Therapy in Chronic Active Ulcerative Colitis.en
dc.typeJournal Articleen
dc.identifier.journaltitleInflammatory Bowel Diseasesen
dc.identifier.affiliationMedicine (University of Melbourne)en
dc.identifier.affiliationGastroenterology and Hepatologyen
dc.identifier.doi10.1093/ibd/izab095en
dc.type.contentTexten
dc.identifier.orcid0000-0002-1627-2057en
dc.identifier.pubmedid33999191
local.name.researcherChoy, Matthew C
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
crisitem.author.deptGastroenterology and Hepatology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

46
checked on Feb 1, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.